发明名称 |
Identifcation of CD8<sup>+</sup> T cells that are CD161<sup>hi </sup>and/or IL18Rα<sup>hi </sup>and have rapid drug efflux capacity |
摘要 |
This invention provides, among other things, methods for the identification and isolation of viable putative long-lived antigen-specific memory CD8+ T cell subsets (CMhi and EMhi) with high surface expression of CD161 and/or IL-18Rα and the capacity to rapidly efflux the fluorescent dye Rh123. |
申请公布号 |
US9090875(B2) |
申请公布日期 |
2015.07.28 |
申请号 |
US200912865221 |
申请日期 |
2009.01.28 |
申请人 |
Fred Hutchinson Cancer Research Center |
发明人 |
Turtle Cameron J.;Riddell Stanley R. |
分类号 |
A61K39/00;C12N5/0783;G01N33/50 |
主分类号 |
A61K39/00 |
代理机构 |
Seed IP Law Group PLLC |
代理人 |
Seed IP Law Group PLLC |
主权项 |
1. A composition comprising: a) a physiological acceptable carrier and b) an isolated population of long-lived memory CD8+ CD161hi IL-18Rαhi T cells, wherein:
the long-lived memory CD8+ CD 161hi IL-18Rαhi T cells make up at least 30% of the total CD8+ T cells in the composition; the long-lived memory CD8+ CD161hi IL-18Rαhi T cells comprise CD95hi memory cells, the CD95hi memory cells being capable of proliferating in response to IL-7 or IL-15 and comprising a population of cells comprising an engineered immunoreceptor; and where the isolated population of long-lived memory CD8+ CD161hi IL-18Rαhi T cells comprises high CD28 surface expression and high MDR-1 mRNA levels, as compared to a CD8+ T cell population with low surface expression of IL-18Rα. |
地址 |
Seattle WA US |